38211 Tumor cell deplete of harvst
Surgery
Also known as: Tumor cell depletion, Leukemic cell depletion
Tumor cell depletion of harvested stem cells, performed to eliminate residual cancer cells from harvested autologous stem cell collections.
Clinical Context
Used in autologous stem cell transplantation to reduce disease relapse by removing contaminating malignant cells from the graft.
RVU Breakdown
| Work RVU | 1.38 |
| Practice Expense RVU | 0.31 |
| Malpractice RVU | 0.15 |
| Total RVU | 1.84 |
Est. Medicare Payment
$61.46
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.